Evaluation of the Incremental Healthcare Economic Burden of Patients with Atrial Fibrillation Treated with Direct-Acting Oral Anticoagulants and Hospitalized for Major Bleeds in the USA
Crossref DOI link: https://doi.org/10.1007/s12325-020-01440-9
Published Online: 2020-07-22
Published Print: 2020-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Deitelzweig, Steven B.
Lovelace, Belinda
Christoph, Mary
Lingohr-Smith, Melissa
Lin, Jay
Fermann, Gregory J.
Funding for this research was provided by:
Portola Pharmaceuticals
Text and Data Mining valid from 2020-07-22
Version of Record valid from 2020-07-22
Article History
Received: 10 June 2020
First Online: 22 July 2020